title: Alternative polyadenylation and nonsense-mediated decay coordinately regulate the human HFE mRNA levels.
abstract: Nonsense-mediated decay (NMD) is an mRNA surveillance pathway that selectively recognizes and degrades defective mRNAs carrying premature translation-termination codons. However, several studies have shown that NMD also targets physiological transcripts that encode full-length proteins, modulating their expression. Indeed, some features of physiological mRNAs can render them NMD-sensitive. Human HFE is a MHC class I protein mainly expressed in the liver that, when mutated, can cause hereditary hemochromatosis, a common genetic disorder of iron metabolism. The HFE gene structure comprises seven exons; although the sixth exon is 1056 base pairs (bp) long, only the first 41 bp encode for amino acids. Thus, the remaining downstream 1015 bp sequence corresponds to the HFE 3' untranslated region (UTR), along with exon seven. Therefore, this 3' UTR encompasses an exon/exon junction, a feature that can make the corresponding physiological transcript NMD-sensitive. Here, we demonstrate that in UPF1-depleted or in cycloheximide-treated HeLa and HepG2 cells the HFE transcripts are clearly upregulated, meaning that the physiological HFE mRNA is in fact an NMD-target. This role of NMD in controlling the HFE expression levels was further confirmed in HeLa cells transiently expressing the HFE human gene. Besides, we show, by 3'-RACE analysis in several human tissues that HFE mRNA expression results from alternative cleavage and polyadenylation at four different sites--two were previously described and two are novel polyadenylation sites: one located at exon six, which confers NMD-resistance to the corresponding transcripts, and another located at exon seven. In addition, we show that the amount of HFE mRNA isoforms resulting from cleavage and polyadenylation at exon seven, although present in both cell lines, is higher in HepG2 cells. These results reveal that NMD and alternative polyadenylation may act coordinately to control HFE mRNA levels, possibly varying its protein expression according to the physiological cellular requirements.
authors.affiliation: Departamento de Genética, Instituto Nacional de Saúde Dr Ricardo Jorge, Lisboa, Portugal.
authors.forename: Rute
authors.initials: R
authors.lastname: Martins
authors.forename: Daniela
authors.initials: D
authors.lastname: Proença
authors.forename: Bruno
authors.initials: B
authors.lastname: Silva
authors.forename: Cristina
authors.initials: C
authors.lastname: Barbosa
authors.forename: Ana Luísa
authors.initials: AL
authors.lastname: Silva
authors.forename: Paula
authors.initials: P
authors.lastname: Faustino
authors.forename: Luísa
authors.initials: L
authors.lastname: Romão
mesh_terms: D018389:Codon, Nonsense; D005091:Exons; D023061:Gene Order; D006367:HeLa Cells; D000071020:Hemochromatosis Protein; D056945:Hep G2 Cells; D015395:Histocompatibility Antigens Class I / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D007438:Introns; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism*; D059365:Nonsense Mediated mRNA Decay; D026723:Polyadenylation; D012333:RNA, Messenger / Q000378:metabolism*
chemical_list: D018389:Codon, Nonsense; C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D012333:RNA, Messenger